Monitoring changes in quality of life in patients with lung cancer under treatment with chemotherapy and co administration of zoledronic acid by using specialized questionnaires

Background: Due to the severity of the primary disease in patients with lung cancer, quality of life (QoL) is often overlooked. Factors that form QoL should be taken in consideration when planning the appropriate treatment and determining therapy targets, because of the increasing frequency of bone...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Cancer
Main Authors: Tremmas, Ioannis, Petsatodis, George, Potoupnis, Michael, Laskou, Stella, Giannakidis, Dimitrios, Mantalovas, Stylianos, Koulouris, Charilaos, Katsaounis, Athanasios, Pavlidis, Efstathios, Amaniti, Aikaterini, Huang, Haidong, Bai, Chong, Shi, Dongchen, Dardas, Athanasios, Zarogoulidis, Paul, Sardeli, Chrisanthi, Konstantinou, Fotis, Katsikogiannis, Nikolaos, Zarogoulidis, Konstantinos, Karapantzos, Ilias, Karapantzou, Chrysanthi, Shen, Xiaping, Kesisoglou, Isaak, Sapalidis, Konstantinos
Formato: Artigo
Idioma:Inglês
Publicado: Ivyspring International Publisher 2018
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5968760/
https://ncbi.nlm.nih.gov/pubmed/29805698
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.24785
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares